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Debate: This house believes that centralised large 
radiotherapy units will provide the best academia and the 
best treatment quality  
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The field of radiation oncology has moved away from a 
generalistic radiotherapy practice to a number of specialized 
areas where radiation oncologists have broadened their 
knowledge outside the field of radiation oncology per se to 
be a better partner in multidisciplinary teams. Most radiation 
oncologists in the larger centers nowadays have only one or 
two areas of expertise (commonly around brain, head & neck, 
breast, lung, upper GI, lower GI, urogenital, gynecology, 
hematology, palliation, etc.). In these areas, radiation 
oncologists can be better counterparts for the organ-
specialists, which have often left all the non-oncological 
work in their specialty to other colleagues.  
With 2-3 areas of expertise per radiation oncologists and 
accounting for sufficient back-up, the minimum size of a 
department treating all categories of patients should be 
around 8 radiation oncologists. Based on 250 new patients 
per radiation oncologist and about 500 new patients per 
linac, the minimum size of a department which covers all 
areas of expertise should be 4 linacs. This size will also allow 
physicists and therapists to specialize, although at a size of 
6-8 machines, this opportunity may be even better. A 
minimum size also makes investments of specialized 
equipped within the department, such as CT, PET-CT or MRI 
feasible and makes it easier to accommodate machine 
breakdown or replacement.  
The economic lifetime of a linac is generally around 10-12 
years. Since the pace of technical innovation is much faster, 
a department with 4-8 linacs has the opportunity to install 
the latest technology every 2-3 years. This, in combination 
with a larger physics group, will allow earlier implementation 
of new treatments. In Europe, the median size of a 
radiotherapy department is between 2 and 3 linacs, with on 
average more than 4 linacs per department in only 6 
countries.  
Sufficiently sized departments are also better equipped for 
research and moving the field forward. The multidisciplinary 
setting and available infrastructure in larger departments will 
help to work off the beaten track. Studies in various tumor 
sites have shown that outcome for patients treated in highly 
accruing (often larger) centers is better.  
However, there is probably also a maximum size. For 
patients, entering a mega-department can be intimidating 
and beyond a certain size, no further benefits may exist. In 
addition, geographical circumstances should be taken into 
consideration. It is well known that easy access to care is 
related to use of radiotherapy. In more remote areas, 
satellite centers may be an alternative, especially if 
infrastructure and staffing can be shared and allow for 
similar protocols and expertise. Especially where resources 
are limited, a close collaboration between centers may 
further improve health care.  
A possible disadvantage of subspecialization could be that 
highly specialized radiation oncologists may lose their 
overview of the developments in the radiotherapy arena and 
the transfer of new ideas and solutions from one indication to 
another may be reduced. For that reason, radiation 
oncologists working with one leg in the tumor-specific field, 
should keep their other leg in the radiation oncology field. 
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Smart-modular-flexible: The essentials for academic 
excellence and high quality  
NoBodis and nobody can believe that there is a general 
relationship between physical size and quality neither in 
biology, politics, industry, administration, culture nor more 
importantly for this forum, in science. Centralisation on the 
other hand is often an imposed structural process and has 
nothing to do with guaranteed high quality performance of 
high quality research. In organic systems and in most 
operational business units high quality growth is 
overwhelmingly present in (early) development i.e. in small 
structures. Moreover biology (organic) systems have a finite 
size to protect them from excessive and dysfunctional 
growth.  
Neither data from radiation oncology industry, health care 
insurance companies, patient advocacy organisations nor 
from international data banks provide published evidence 
that large centralised radiation oncology units provide a 
higher treatment quality compared with small units. 
Moreover there is no international accepted definition of 
“small” and “large” RO unit. Large centralised radiation 
oncology units might produce more academic quantity 
because it is in their to do list. However academic quality is 
never a matter of size and/or centralisation. Most 
breakthrough innovations arise by chance, in small teams of 
6-12 researches and fostered by a creative und productive 
environment (The majority of Nobel prizes laureates are 
citizens of small countries).  
If you have to choose between one monopolistic large 
radiation oncology department and several smaller units 
think about similar choices made historically by politics or by 
evolution. The audience should carefully consider the 
scientific information provided in this debate not according 
to the evidence but also by common sense, gut feeling and 
empathy (e.g. in what type of radiation oncology 
environment would you like to work and/or be taken care of 
as a patient: Familial or military?). And by the way Radium, 
the “potion magique” of radiation oncology, was discovered 
in a storeroom and introduced into clinics by a handful 
enthusiastic scientists.  
To pave the way for a constructive debate consider this: 
Based on the existing local health care systems in Europe 
both types of radiation oncology units (large and small) can 
co-exist and improve each other by cross-feeding. The IAEA 
has published recommendations as to how national radiation 
oncology services should be established, specifically in low- 
and middle-income countries with little or no RO 
infrastructure. Their recommendation is to start with small 
primary centers and step by step establish a network with a 
few secondary and eventually one tertiary (national 
reference) RO center(s). Such tailored RO networks allow 
proper allocation of professional skills and resources to each 
center including modern communications tools like 
telemedicine to optimize patient care especially where long 
distances might prevent patients from reaching the larger 
center(s).  
In a multidisciplinary environment such as a RO clinic, the 
quality (education, experience, research as commitment for 
continuous improvement) of the staff will always be more 
important than quantity. 
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